1. Home
  2. KODK vs KALV Comparison

KODK vs KALV Comparison

Compare KODK & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$7.93

Market Cap

697.0M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.32

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
KALV
Founded
1880
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.0M
757.7M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
KODK
KALV
Price
$7.93
$16.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$30.00
AVG Volume (30 Days)
723.0K
761.7K
Earning Date
03-12-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,114,000,000.00
$50,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$4.93
$9.83
52 Week High
$9.96
$19.00

Technical Indicators

Market Signals
Indicator
KODK
KALV
Relative Strength Index (RSI) 62.85 51.08
Support Level $6.44 $14.59
Resistance Level $9.01 $17.30
Average True Range (ATR) 0.38 1.07
MACD 0.12 -0.09
Stochastic Oscillator 82.28 35.60

Price Performance

Historical Comparison
KODK
KALV

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: